Hepatitis: A rare, but important, complication of infliximab therapy for psoriasis [8]

Clinical and Experimental Dermatology

Volumn 31, Issue 3, 2006, Pages 460-461

  Wahie, S ^a   Alexandroff, A ^a   Reynolds, N J ^a,b  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b BAD Biological Interventions for Psoriasis Guidelines and Register Working Group

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; ETANERCEPT; ETRETIN; FUMARIC ACID; HYDROXYUREA; INFLIXIMAB; METHOTREXATE; PSORALEN;

ADULT; ANAMNESIS; CASE REPORT; DRUG INFUSION; DRUG RESPONSE; HEPATITIS; HUMAN; LABORATORY TEST; LETTER; LIVER FUNCTION TEST; MALE; PRIORITY JOURNAL; PSORIASIS; PUVA;

ANTIBODIES, MONOCLONAL; DERMATOLOGIC AGENTS; HEPATITIS, TOXIC; HUMANS; MALE; MIDDLE AGED; PSORIASIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33645349854     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2006.02086.x     Document Type: Letter

References (5)

1. US Food and Drugs Administration. Warning on severe hepatotoxicity with RemicadeRockville: US Food and Drugs Administration MedWatch 2004
2. Schiemann U Kellner H Gastrointestinal side effects in the therapy of rheumatologic diseases Z Fur Gastroenterologie 2002 40 937 43
3. Peterson JR Hsu FC Simkin PA Wener MH Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection Ann Rheum Dis 2003 62 1078 82
4. Michel M Duvoux C Hezode C Cherqui D Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset Still's disease J Rheumatol 2003 30 1624 5
5. Ostuni P Botsios C Punzi L Sfriso P Todesco S Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate Ann Rheum Dis 2003 62 686 7